Holen Sie sich die Stockscreener-App
15.78
2.27%
0.35
Vorhandelsmarkt:
15.61
-0.17
-1.08%
Schlusskurs vom Vortag:
$15.43
Offen:
$15.69
24-Stunden-Volumen:
4.12M
Relative Volume:
4.21
Marktkapitalisierung:
$950.50M
Einnahmen:
$434.53M
Nettoeinkommen (Verlust:
$-42.72M
KGV:
-21.32
EPS:
-0.74
Netto-Cashflow:
$21.88M
1W Leistung:
-22.57%
1M Leistung:
-30.24%
6M Leistung:
-43.68%
1J Leistung:
-34.63%
1-Tages-Spanne:
$15.46
$16.58
1-Wochen-Bereich:
$15.41
$21.24
52-Wochen-Spanne:
$15.41
$32.76
Phreesia Inc Stock (PHR) Company Profile
Firmenname
Phreesia Inc
Sektor
Branche
Telefon
888-654-7473
Adresse
1521 CONCORD PIKE, WILMINGTON
Vergleichen Sie PHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHR
Phreesia Inc
|
15.78 | 929.42M | 434.53M | -42.72M | 21.88M | -0.74 |
|
VEEV
Veeva Systems Inc
|
229.16 | 38.14B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
75.07 | 13.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.04 | 8.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.73 | 7.97B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.20 | 6.39B | 11.99B | 24.18M | 234.31M | 0.2956 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-09-05 | Fortgesetzt | DA Davidson | Buy |
| 2025-08-27 | Eingeleitet | Mizuho | Outperform |
| 2025-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-26 | Eingeleitet | Truist | Buy |
| 2024-01-17 | Hochstufung | DA Davidson | Neutral → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-01-04 | Bestätigt | Needham | Buy |
| 2022-12-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-13 | Eingeleitet | DA Davidson | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-01-06 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-08-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-08 | Eingeleitet | Berenberg | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-01 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-11-11 | Eingeleitet | Stephens | Overweight |
| 2020-10-27 | Eingeleitet | Needham | Buy |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Neutral |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-01-31 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-01-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-12-20 | Eingeleitet | Raymond James | Outperform |
| 2019-10-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-13 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-12 | Eingeleitet | Wells Fargo | Outperform |
| 2019-08-12 | Eingeleitet | William Blair | Outperform |
| 2019-07-23 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Phreesia Inc Aktie (PHR) Neueste Nachrichten
PHR Analyst Ratings Update: Mizuho Lowers Price Target | PHR Sto - GuruFocus
Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance Singapore
MercyOne partners with Phreesia to automate social needs screenings - Business Record
PHR Stock: Baird Lowers Price Target, Maintains Outperform Ratin - GuruFocus
Phreesia stock hits 52-week low at $18.17 amid market challenges - Investing.com Canada
Why Phreesia Stock Plummeted by 23% Today - Yahoo Finance
Mizuho lowers Phreesia stock price target to $28 on pharma spending concerns - Investing.com Nigeria
Phreesia, Inc. SEC 10-Q Report - TradingView
PHR: Citigroup Lowers Price Target While Maintaining Buy Rating - GuruFocus
Is Phreesia a Hidden Opportunity After Recent Digital Patient Intake Partnerships? - Yahoo Finance
Needham Reiterates Buy Rating for Phreesia (PHR) with $35 Price Target | PHR Stock News - GuruFocus
Canaccord Genuity Lowers Price Target for Phreesia (PHR) | PHR S - GuruFocus
Canaccord Genuity lowers Phreesia stock price target to $33 on revenue outlook - Investing.com Nigeria
DA Davidson reiterates Buy rating on Phreesia stock, maintains $35 price target - Investing.com Nigeria
Phreesia (PHR) Gains Momentum with New "Overweight" Rating by Ba - GuruFocus
Phreesia Posts Solid Earnings But Shares Drop Anyway - Yahoo Finance
Phreesia, Inc. (NYSE:PHR) Q3 2026 earnings call transcript - MSN
Phreesia, Inc. (NYSE:PHR) Q3 2026 Earnings Call Transcript - Insider Monkey
Citizens reiterates Market Outperform rating on Phreesia stock at $34 By Investing.com - Investing.com Canada
Citizens reiterates Market Outperform rating on Phreesia stock at $34 - Investing.com
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say - sharewise.com
Earnings call transcript: Phreesia Q3 2025 earnings beat forecasts, stock rises By Investing.com - Investing.com South Africa
Phreesia Inc (PHR) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance UK
Phreesia Reports Strong Q3 2026 Earnings and Positive Outlook - TipRanks
Phreesia (PHR) Reports Strong Q3 with Revenue and EBITDA Growth - GuruFocus
Phreesia Q3 FY2026 slides: revenue up 13%, completes $160M AccessOne acquisition - Investing.com India
Earnings call transcript: Phreesia Q3 2025 earnings beat forecasts, stock rises - Investing.com
Phreesia Q3 2026 Earnings Call Transcript - MarketBeat
Phreesia adjusts fiscal 2026 revenue outlook; introduces FY27 guidance - Seeking Alpha
Phreesia: Fiscal Q3 Earnings Snapshot - New Haven Register
PHREESIA ($PHR) Q3 2026 Earnings Results - Quiver Quantitative
Phreesia (PHR) Projects Revenue Growth and Adjusted EBITDA for F - GuruFocus
PHR Updates Fiscal 2026 Revenue and EBITDA Outlook - GuruFocus
Phreesia Swings to Q3 Earnings, Revenue Increase; Introduces Fiscal 2027 Outlook - marketscreener.com
Phreesia shares rise as company swings to profit in third quarter By Investing.com - Investing.com South Africa
Phreesia Announces Third Quarter Fiscal 2026 Results and Introduces Fiscal 2027 Outlook - TradingView
Phreesia shares rise as company swings to profit in third quarter - Investing.com Canada
(PHR) Phreesia Expects Fiscal 2027 Revenue Range $545M-$559M, vs. FactSet Est of $539.7M - marketscreener.com
(PHR) Phreesia Now Expects Fiscal 2026 Revenue Range $479M-$481M, vs. FactSet Est of $478.6M - marketscreener.com
Earnings Flash (PHR) Phreesia, Inc. Reports Q3 Revenue $120.3M, vs. FactSet Est of $120.0M - marketscreener.com
Phreesia (NYSE: PHR) posts $4.3M Q3 profit, sets 2027 revenue growth outlook - Stock Titan
United StatesCahill Represents Lead Arranger In Phreesia’s $110 Million Credit Facility - Mondaq
Phreesia Stock (PHR) Under Pressure Ahead of Earnings: What to Expect - AskTraders.com
Stock Market Today: Dow Futures Pare Losses, S&P 500, Nasdaq Gain— Carvana, Confluent, Toll Brothers In Focus (UPDATED) - Benzinga
Needham Reiterates "Buy" Rating for Phreesia (PHR) with $35 Targ - GuruFocus
Toll Brothers, Phreesia And 3 Stocks To Watch Heading Into MondayToll Brothers (NYSE:TOL) - Benzinga
Finanzdaten der Phreesia Inc-Aktie (PHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.74%
4.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):